EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...

A population-based cross-sectional study published in Clinical Rheumatology reveals that individuals with rheumatoid ...

Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

A recent study discovered an exponential rise in rheumatoid arthritis all across the globe.Researchers found that the ...

Methotrexate intolerance in RA patients was not linked to dosing frequency or administration route, suggesting other factors ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...

The incidence rate of rheumatoid arthritis (RA) increased globally from 1990 to 2021, with the heaviest burden born by ...

This alliance highlights Scipher Medicine's commitment to advancing precision medicine globally, as well as Grupo Amarey's leadershi ...

Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company redefining the treatment of autoimmune and ...